Bristol-Myers Squibb spol. s r.o. won Czechia – Antineoplastic agents – LP s obsahem nivolumabu 2024 from Fakultní nemocnice Olomouc

Fakultní nemocnice Olomouc · Czech Republic government award

GlobalGov surfaces government contract awards from around the world, including the markets your competitors overlook.

$23.8M
Award Value
September 6, 2024
Award Date
Awarded
Status

Award Overview

Bristol-Myers Squibb spol. s r.o. was awarded Czechia – Antineoplastic agents – LP s obsahem nivolumabu 2024 by Fakultní nemocnice Olomouc in Czech Republic, tracked by GlobalGov. The award is valued at $23.8M. It was awarded on September 6, 2024. Full award details and the issuing agency are below.

See who is winning government contracts in this market — and the open opportunities coming next. Track awards, incumbents, and recompetes worldwide. Free for 14 days, no card.

Start Free

Award Details

AwardeeBristol-Myers Squibb spol. s r.o.
Awardee countryCzech Republic
Awarding agencyFakultní nemocnice Olomouc
CountryCzech Republic
Award value$23.8M
Award dateSeptember 6, 2024
Last verifiedSeptember 1, 2026

Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.

Track every Czech Republic contract award and the opportunities behind them. Free for 14 days.

Get incumbent intelligence, recompete alerts, and deadline tracking for this market and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required